Simplex Trading’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-493,445
| Closed | -$3.38M | – | 9543 |
|
|
2025
Q4 | $977K | Buy |
493,445
+453,955
| +1,150% | +$1.03M | ﹤0.01% | 2627 |
|
|
2025
Q3 | $97K | Sell |
39,490
-23,285
| -37% | -$60K | ﹤0.01% | 5779 |
|
|
2025
Q2 | $165K | Buy |
+62,775
| New | +$169K | ﹤0.01% | 4710 |
|
|
2024
Q1 | – | Sell |
-52,314
| Closed | -$237K | – | 9282 |
|
|
2023
Q4 | $262K | Buy |
52,314
+43,431
| +489% | +$136K | ﹤0.01% | 4383 |
|
|
2023
Q3 | $15K | Buy |
+8,883
| New | +$17.8K | ﹤0.01% | 6872 |
|
|
2023
Q2 | – | Sell |
-109,766
| Closed | -$310K | – | 9393 |
|
|
2023
Q1 | $199K | Buy |
109,766
+107,776
| +5,416% | +$335K | ﹤0.01% | 4327 |
|
|
2022
Q4 | $10K | Sell |
1,990
-53,262
| -96% | -$292K | ﹤0.01% | 7538 |
|
|
2022
Q3 | $274K | Buy |
55,252
+14,400
| +35% | +$65.6K | ﹤0.01% | 4197 |
|
|
2022
Q2 | $151K | Buy |
40,852
+16,716
| +69% | +$67.1K | ﹤0.01% | 4995 |
|
|
2022
Q1 | $135K | Sell |
24,136
-56,312
| -70% | -$345K | ﹤0.01% | 5720 |
|
|
2021
Q4 | $489K | Buy |
80,448
+77,108
| +2,309% | +$579K | ﹤0.01% | 3839 |
|
|
2021
Q3 | $47K | Buy |
3,340
+449
| +16% | +$4.94K | ﹤0.01% | 7568 |
|
|
2021
Q2 | $41K | Sell |
2,891
-36,569
| -93% | -$604K | ﹤0.01% | 7892 |
|
|
2021
Q1 | $936K | Sell |
39,460
-28,528
| -42% | -$740K | ﹤0.01% | 2478 |
|
|
2020
Q4 | $906K | Buy |
67,988
+46,938
| +223% | +$452K | ﹤0.01% | 2695 |
|
|
2020
Q3 | $145K | Sell |
21,050
-31,218
| -60% | -$311K | ﹤0.01% | 4494 |
|
|
2020
Q2 | $641K | Buy |
52,268
+42,814
| +453% | +$242K | ﹤0.01% | 2626 |
|
|
2020
Q1 | $27K | Sell |
9,454
-9,560
| -50% | -$47.9K | ﹤0.01% | 5705 |
|
|
2019
Q4 | $72K | Buy |
+19,014
| New | +$32.4K | ﹤0.01% | 4852 |
|
|
2019
Q3 | – | Sell |
-15,656
| Closed | -$19.4K | – | 7517 |
|
|
2019
Q2 | $15K | Sell |
15,656
-43,583
| -74% | -$50.3K | ﹤0.01% | 5836 |
|
|
2019
Q1 | $93K | Buy |
59,239
+45,217
| +322% | +$56.8K | ﹤0.01% | 4411 |
|
|
2018
Q4 | $16K | Buy |
14,022
+13,958
| +21,809% | +$31.9K | ﹤0.01% | 5514 |
|
|
2018
Q3 | $0 | Sell |
64
-215
| -77% | -$680 | ﹤0.01% | 7679 |
|
|
2018
Q2 | $0 | Sell |
279
-1,060
| -79% | -$3.92K | ﹤0.01% | 7573 |
|
|
2018
Q1 | $5K | Sell |
1,339
-13,010
| -91% | -$57K | ﹤0.01% | 4639 |
|
|
2017
Q4 | $64K | Buy |
14,349
+3,959
| +38% | +$18.7K | ﹤0.01% | 2197 |
|
|
2017
Q3 | $56K | Buy |
+10,390
| New | +$64K | ﹤0.01% | 2203 |
|
|
2015
Q4 | – | Sell |
-1,707
| Closed | -$25.3K | – | 5700 |
|
|
2015
Q3 | $19K | Buy |
+1,707
| New | +$37.3K | ﹤0.01% | 2845 |
|
Other funds holding IBRX
Simplex Trading's IBRX Position: Q1 2026 in Review
Simplex Trading sold out of ImmunityBio (IBRX) in Q1 2026, closing a stake of 493,445 shares — an estimated $3.38M sold.
Simplex Trading first reported a position in IBRX in Q3 2015 and held it in 28 quarters. The position peaked at $977K in Q4 2025. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.
- Simplex Trading reported no remaining ImmunityBio position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 493,445 ImmunityBio shares in Q1 2026, an estimated $3.38M.
- Simplex Trading first reported a position in ImmunityBio in Q3 2015 and held it in 28 quarters.
- Simplex Trading's ImmunityBio position peaked at $977K in Q4 2025.
- 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.